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Background: Parkinson’s disease follows a chronic course, and therefore quality of life is
important to assess in relation to rehabilitation programs for persons with the disease.
Aim: To examine whether a brief rehabilitation program can promote positive changes in
functional status, general self-efficacy, and quality of life and to examine factors associated
with changes in quality of life.
Methods: Patients with Parkinson’s disease (n=83) completed the General Self-Efficacy
Scale and the Parkinson’s Disease Questionnaire at the beginning of a rehabilitation program
and at three weeks follow-up. Within-person changes were analyzed with paired t-tests. A
hierarchical linear regression was conducted to assess the independent associations between
the independent variables and changes in quality of life during the three weeks program,
while adjusting for the covariance between the independent variables.
Results: Patients reported higher functional status (d=0.37, p<0.001), general self-efficacy
(d =0.28, p<0.01), and quality of life (d=0.32, p<0.001) at three weeks follow-up, compared
to their baseline scores. The regression analysis showed that having a better initial functional
status (β =−0.26, p<0.05) and lower quality of life (β =0.51, p<0.001) were associated with
more improvements in quality of life.
Conclusion: The study suggests that actual functioning in persons with Parkinson’s disease
is a better predictor of improved quality of life than self-efficacy beliefs and that those who
have lower levels of initial quality of life benefit more from rehabilitation.
Keywords: functional status Parkinson’s disease, multidisciplinary rehabilitation program,
self-efficacy, quality of life
Introduction
Parkinson’s disease can severely threaten self-efficacy and quality of life, and these
factors may be reduced with disease progression. In a study by Fujii and coworkers
on 143 patients with Parkinson’s disease in Tokyo, it was suggested that to increase
self-efficacy among patients with Parkinson’s disease, social and psychological
support and providing health education were important.1 Additionally, self-efficacy
has been found to be important for effective disease management and for adherence
to medication in chronic diseases, such as diabetes and juvenile chronic arthritis,
suggesting that self-efficacy can predict disease management.2 These factors are
also presumed to affect a person with Parkinson’s disease. Less depression and
more well-being have been linked with individuals who feel mastery over life
activities and maintain participation in them.3,4
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Motor symptoms, such as tremor, rigidity and bradykine-
sia and non-motor symptoms, such as anxiety, depression,
fatigue, cognitive impairment, sleep disorders and restless
legs, can result in increased dependence in activities of daily
living (ADLs), loss of autonomy, social isolation, and falls.5–
8 Non-motor symptoms occur in 90% of the people with
Parkinson’s disease, and research has shown that non-motor
symptoms have a greater impact on health-related quality of
life thanmotor symptoms alone.7,9 Reduced functionalmobi-
lity and reduced ability to perform ADLs have been closely
linked to quality of life in persons with Parkinson’s disease.10
Consequently, as Parkinson’s disease symptoms progress and
worsen, maintaining independence in ADLs may decrease,
resulting in reduced quality of life.
For several years, exercise-based programs have been the
main intervention used when treating persons with
Parkinson’s disease, and they have been identified as bene-
ficial for improving both physical functioning and quality of
life.5,11 Giardini and coworkers found that among persons
with Parkinson’s disease, enhanced functioning and redis-
covered autonomy were reported after intensive rehabilita-
tion treatment.12 Consequently, with improved physical and
functional capabilities, participants claimed to have gained
better symptoms control and overall body control, denoting
higher perceived self-efficacy. However, the weakness of
exercise-based programs alone is that they do not necessarily
address the specific non-motor symptoms occurring in
Parkinson’s disease.7,13 When compared to a control group
receiving care only from a general neurologist, patients in an
intervention group receiving care from a movement disorder
specialist, Parkinson’s disease nurses, and social workers,
improved significantly in quality of life.14 This supports the
notion that a multidisciplinary rehabilitation approach parti-
cularly tailored to the challenges experienced by patients
with Parkinson’s disease can produce favorable outcomes.
By addressing both motor and non-motor symptoms, multi-
disciplinary rehabilitation programs may be better equipped
to assist the patient with Parkinson’s disease to self-manage
their disease, to increase their self-efficacy, and ultimately to
improve their quality of life.15 However, while some research
studies indicate that rehabilitation programs can improve
self-perceived performance in ADLs, general functioning,
and quality of life,16–18 research on the effects of multidisci-
plinary rehabilitation programs on self-efficacy in persons
with Parkinson’s disease is scarce.19
Furthermore, better exercise capacity and higher self-
efficacy prior to starting a rehabilitation program have
been associated with improved quality of life,20 and
rehabilitation programs have been found to reduce the
psychosocial impact of disease in a number of studies on
chronic and progressive diseases, such as multiple sclero-
sis, chronic obstructive pulmonary disease, cancer, and
myocardial infarction.20–23 This evidence suggests that
self-efficacy is important to target in rehabilitation
programs.20 However, to date, there are no similar studies
concerned with patients with Parkinson’s disease.
The complexity of Parkinson’s disease and adverse bur-
den pertained to living with the disease may pose chal-
lenges on sustaining self-efficacy and compromise quality
of life. However, modern multidisciplinary rehabilitation
programs, frequently including the expertise of occupational
therapists, explicitly aim at increasing a person’s sense of
self-efficacy15 and to inspire a patient’s sense of mastery in
everyday challenges. Promoting self-efficacy through activ-
ities is also considered a core element of occupational
therapy,24 and knowledge about self-efficacy and quality
of life, and the associations between them may contribute
to shape and strengthen therapy interventions for patients
with Parkinson’s Disease.
Study aim. The aim of the study was to examine
(i) whether positive changes in functional status, general
self-efficacy, and quality of life occurred among patients
with Parkinson’s disease after a brief multidisciplinary
rehabilitation program and (ii) the factors associated with
changes in quality of life.
Methods
Design and context
The study had a prospective longitudinal design. The data
material was collected at a specialized rehabilitation center
in Baerum, Norway.
Intervention
The multidisciplinary rehabilitation program had a duration of
three weeks and was an inpatient program. Upon
arrival, participants were awarded a primary contact to ensure
a unified team working toward goals set by the participant
him/herself. The multidisciplinary team consisted of 10 dif-
ferent professions, such as occupational therapists, physical
therapists, doctors, neurologists, nurses, sports educators, cog-
nitive behavioral therapists, and nutritionists.25 Commencing
the multidisciplinary rehabilitation program, participants were
assessed by the relevant professional/s and typically had close
follow-up the first week with individual and group-based
exercise. Participants would see the physical therapist
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individually at least three times a week, 30 mins each time,
and when required participants would have one on one with
the occupational therapist, speech therapist and/or the sports
educator. The occupational therapist would assess cognitive
impairment when needed and create a training program sui-
table for the participants’ needs. Additionally, participants had
a weekly program set specifically up for him/her, containing
disease-specific group-based exercises and physical activity
group exercises not specific to disease that they were highly
encouraged to attend every day. The training programs typi-
cally followed the neuroplasticity-principled Parkinson
Wellness Recovery exercises with the intent of slowing dis-
ease progression, improve symptoms, restore function, and
increase quality of life.26 To address non-motor symptoms,
participants also had the option of going to disease-specific
educational groups, where they, for example, would learn
about nutrition and medication, talk to peers, and ask the
professionals questions, and they had two weekly group-
based speech therapy training sessions. Based on need, cog-
nitive behavioral therapy was also available. Towards the end
of the program, participants were expected to be able to per-
form individually tailored exercises and activities, with the
aim of carrying it over to everyday life.
Participation recruitment and inclusion
criteria
Patients with Parkinson’s disease (n=87) were individually
recruited for the study upon arrival at the rehabilitation center
during January 2018 through May 2018. All of the patients
with Parkinson’s disease who were admitted during the study
period were asked to participate in the study as long as they
were admitted for treatment, met the diagnostic criteria,
provided written informed consent, and were classified
within Hoehn and Yahr stages I-IV.27 Hoehn and Yahr
(H&Y) describe the different stages of Parkinson’s disease,
from mild to severe, on an arbitrary staging scale from I to
V.27 Stage I is characterized by unilateral involvement only
with minimal or no functional disability, while stage V is
characterized by confinement to bed or wheelchair unless
aided. Eighteen (21.7%) participants were in Hoehn and Yahr
stage I, 38 (45.8%) in stage II, 24 (28.9%) in stage III, and 3
(3.6%) participants were in stage IV.
Measures
The questionnaires (PDQ-39 and GSE: see below for
description), used before and after the three weeks rehabi-
litation program were handed out the first day with written
and verbal instructions. A sociodemographic questionnaire
containing age, gender, level of education, and Parkinson’s
disease duration was included in the handout. Scores on
functional status by the MiniBestTest (MBT)28 were later
extracted from participants’ records upon completion of
the rehabilitation program.
The Parkinson’s Disease Questionnaire 39 was devel-
oped for assessing quality of life in persons with
Parkinson’s disease29 and has been found to have satisfac-
tory internal consistency (Cronbach’s α = 0.89) and con-
vergent validity in relation to the Hoehn and Yahr (r=0.51,
p˂0.001).29,30 Test–retest reliability has been found to be
adequate (r ranging 0.79–0.93).31 The instrument consists
of 39 questions addressing the issues of mobility, ADLs,
emotional well-being, stigma, social support, cognition,
communication, and bodily discomfort. For all the items
on the 8-step scale, the respondents are asked to indicate
how often they experience difficulties ranging from “never”
to “always or cannot do at all”. The score range is 39–195,
with higher scores indicating lower quality of life. The
change score was calculated by subtracting the follow-up
score from the initial score; thus, a more positive change
score reflected more improvements in quality of life.
The General Self-efficacy Scale consists of 10 items
(scored 1–4; “not at all true” to “exactly true”) and was
designed to assess optimistic self-beliefs related to coping
with a variety of demands in life.32 The scale explicitly
refers to personal agency, ie, the belief that one’s actions are
the cause of successful outcomes. It is a well-known and
accepted instrument that measures one underlying construct
of general self-efficacy.33 Score range is 10–40, with higher
scores indicating higher general self-efficacy.
Functional status was measured with the MBT,28 and the
assessment was performed by the physical therapist. The
MBT is a tool that was developed for predicting a person’s
likelihood of falls by assessing dynamic balance.28 The
MBT is composed of 14 items on a 3-level ordinal scale,
with higher scores indicating higher functional status. The
participant demonstrates specific tasks and is subsequently
classified as having normal functioning (2 points), moderate
problems (1 point), or severe problems (0 points). Higher
scores indicate less risk of falling.
Data analysis
Scale scores were computed provided that the participants
had less than 20% missing scores on the relevant scale
items. In the eventual case of missing values, values were
replaced with the mean of the completed items. Cases with
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missing values subsequent to the replacement procedure
were deleted analysis by analysis (casewise deletion).
Thus, n varied between analyses.
Initial descriptive analyses used means (M) and stan-
dard deviation (SD) for continuous variables and frequen-
cies and percentages for categorical variables. Internal
consistency of the PDQ-39 scale and the general self-
efficacy scale were examined with Cronbach’s α, and
coefficients exceeding 0.70 were considered acceptable.
Several methods were employed to assess scores dis-
tribution on the scale. We found that the mean and median
values were fairly similar, measures of skewness were all
within the generally accepted limits (skewness <2), and
the visual inspection of Q–Q plots, histogram, and box
plot indicated a distribution resembling the normal distri-
bution. However, the baseline measures of functional sta-
tus, general self-efficacy, and quality of life produced
significant Kolmogorov–Smirnov test results. Thus, non-
parametric tests were conducted to ensure that the same
results were produced by the two methods of statistical
testing. As the results were the same, we decided to
proceed with parametric analyses as appropriate.
Independent t-tests and Chi-Square tests were con-
ducted to analyze differences between men and women.
Paired t-tests were conducted to analyze the differences in
mean scores (functional status, general self-efficacy, and
quality of life) between baseline and three weeks follow-
up. Non-parametric tests were conducted to ensure same
results. A hierarchical linear regression analysis was con-
ducted to assess the independent associations between the
independent variables and changes in the quality of life
scale score while adjusting for the covariance between the
independent variables. There were two subsequent models,
where Model 1 included the independent demographic
variables age, gender, and education. Model 2 also
included Parkinson’s disease duration, functional status
(MBT), baseline general self-efficacy scores, and baseline
quality of life scores. All data were analyzed using the
statistical software IBM SPSS 25 for Windows.34
Statistical significance was set at p<0.05.
Ethics
Prior to commencing the study, approval from the
Norwegian Regional Committee for Medical and Health
Research Ethics (project number 2017/1584) was obtained.
Participants provided a written informed consent to partici-
pate in the study, after having been informed that participa-
tion was voluntary, that opting not to participate would not
adversely affect their rehabilitation, and that their responses
would be treated in confidence. The study was conducted in
accordance with the Declaration of Helsinki.
Results
Sample characteristics
One person did not meet the inclusion criteria, two left the
rehabilitation center after only a few days for various reasons,
and one left without filling out the questionnaires. These were
all removed from the data set prior to the analyses.
The sociodemographic characteristics of the sample are
displayed in Table 1. Eighty-three (n=83) participants
completed the measures at baseline and at three weeks
follow-up, and these constituted the study sample.
Among the participants, the mean age of the sample was
69.0 years (SD =8.3 years), with 48 being male (57.8%)
and 35 (42.2%) female. The sample’s mean Parkinson’s
Table 1 Characteristics of the study participants
All (n=83)
M (SD)
Women (n=35)
M (SD)
Men (n=48)
M (SD)
p
Age (n=83) 69.0 (8.3) 70.3 (7.2) 68.0 (9.0) 0.21
Parkinson’s disease duration (n=81) 5.0 (3.7) 5.4 (3.6) 4.7 (3.8) 0.42
Education level (n=81) n (%) n (%) n (%) 0.51
Higher education 51 (63.0) 20 (58.8) 31 (66.0)
Lower education 30 (37.0) 14 (41.2) 16 (34.0)
M (SD) M (SD) M (SD)
Functional status (MBT) (n=74) 23.3 (3.8) 23.6 (3.8) 23.0 (3.9) 0.46
General self-efficacy (n=82) 26.0 (6.5) 25.3 (6.8) 26.5 (6.2) 0.44
Quality of life (n=77) 79.0 (20.7) 82.2 (20.6) 76.8 (20.7) 0.26
Note: On categorical variables with missing responses (ie, n<83), the valid percent is reported. Statistical tests are independent t-tests (continuous variables) and Chi-square
tests (categorical variables).
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disease duration was 5.0 years (SD=3.7 years). Fifty-one
participants (63.0%) reported having three years of higher
education or more.
Internal consistency for the quality of life scale (valid
for 72.3% of the sample) was Cronbach’s α =0.94, and for
the general self-efficacy scale (valid for 91.6% of the
sample) Cronbach’s α =0.91, thus, indicating very good
internal consistency. Mean scores for baseline general self-
efficacy was 25.3 (SD=6.8) for women and 26.5 (SD=6.2)
for men (ns). The mean scores for baseline quality of life
for women were 82.2 (SD=20.6) and 76.8 (SD=20.7) for
men (ns). The mean score for baseline functional status
(MBT) for women was 23.6 (SD=3.8) and 23.0 (SD=3.9)
for men (ns).
Changes in functional status, general self-
efficacy, and quality of life
Functional status scores changed from baseline (M=23.5,
SD=3.3) to three weeks follow-up (M =24.7, SD=3.1,
p<0.001, Cohen’s d =0.37), suggesting improved func-
tional status at three weeks follow-up. There was a change
in general self-efficacy score from baseline (M=26.0,
SD=6.2) to three weeks follow-up (M =27.8, SD=6.7,
p<0.01, Cohen’s d =0.28), suggesting higher general self-
efficacy at three weeks follow-up. Lastly, quality of life
changed from baseline (M=77.9, SD=19.6) to three weeks
follow-up (M=71.7, SD=18.6, p<0.001, Cohen’s d =0.32),
denoting improved quality of life at follow-up.
Associations with changes in quality of life
Table 2 shows the results from the regression analyses.
Hierarchical linear regressions were conducted to assess
associations between each of the independent variables
and the changes in quality of life. In Model 1, the demo-
graphic variables age, gender, and education explained
7.6% (ns) of the outcome variance. When included in
Model 2, Parkinson’s disease duration, functional status
(MBT), baseline general self-efficacy and baseline quality
of life explained an additional 20.9% of the total variance
in quality of life change. Better functional status (MBT;
β =0.26, p<0.05) and lower baseline quality of life
(β =0.51, p<0.001) were significantly associated with
more improvements in quality of life.
The changes in quality of life scores as moderated by
initial levels of functioning and quality of life are pre-
sented in Figures 1 and 2. For those with initial levels of
functioning at the median value (Md =24.0) or higher,
quality of life improved markedly between baseline
(M =72.6, SD=22.3) and three weeks follow-up (M=62.1,
SD=15.4, p<0.001, Cohen’s d=0.55). For those with initial
levels of functioning lower than the median value, quality
of life improved, but not as markedly, from baseline
(M=78.4, SD=16.3) to three weeks follow-up (M=74.5,
SD=17.2, p<0.01, Cohen’s d=0.23).
For those with initial quality of life scores lower than
the median value (Md=77.0: ie, those with better quality of
life), quality of life improved from baseline (M=61.8,
SD=8.3) to three weeks follow-up (M=58.5, SD=9.9,
p<0.01, Cohen’s d=0.37). For those with initial quality of
life scores at the median value or above (ie, those with
poorer quality of life), quality of life improved markedly
from baseline (M=95.3, SD=11.7) to three weeks follow-
up (M=86.1, SD =15.1, p<0.001, Cohen’s d =0.68). In
other words, participants who had better initial function-
ing, and lower initial quality of life, increased their quality
of life more in comparison to their counterparts.
Discussion
To the best of our knowledge, this is the first study to
examine changes in quality of life and factors associated
with the change, during a three-week rehabilitation pro-
gram for patients with Parkinson’s disease. The study
suggests that a three-week multidisciplinary rehabilitation
program can promote positive change in functional status,
general self-efficacy, and quality of life. Moreover, the
Table 2 Hierarchical linear regression analyses showing direct
associations with changes in quality of life
Independent variables Model 1 Model 2
Age −0.20 −0.13
Sex 0.15 0.06
Education −0.09 0.02
Explained variance 7.6%
Parkinson’s disease duration −0.05
Functional status (MBT) 0.26*
Baseline general self-efficacy 0.06
Baseline quality of life 0.51**
R2 change 20.9%**
Explained variance 28.5% **
Notes: Table content is standardized beta weights, indicating the strength of
association with changes in quality of life. Variable coding: Male =1, female =2.
Higher education =1, lower education =0. Higher functional status score indicates
better functioning, and higher general self-efficacy scores indicate higher general
self-efficacy, whereas higher quality of life scores indicate lower quality of life.
Higher quality of life change score indicates more improvement.
* p<0.05, ** p<0.01.
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regression models showed that higher baseline functional
status and lower baseline quality of life levels were asso-
ciated with more improvement in quality of life.
Our results showed that functional status, general self-
efficacy, and quality of life improved from baseline to
three weeks follow-up. On average, participants saw a
1.2 point improvement in functional status (MBT), 1.8
point improvement in general self-efficacy, and a 6.2
point improvement in quality of life. The minimal clini-
cally detectable change in PDQ-39 has been found to be
72.6
62.1
78.4
74.5
50
55
60
65
70
75
80
85
90
95
100
Baseline scores Three weeks follow-up scores
Higher functioning Lower functioning
Figure 1 Changes in quality of life moderated by initial functional status.
61.8
58.5
95.3
86.1
50
55
60
65
70
75
80
85
90
95
100
Baseline scores Three weeks follow-up scores
Higher Quality of Life Lower Quality of Life
Figure 2 Changes in quality of life moderated by initial quality of life scores.
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−4.72/+4.22 (improvement/worsening),35 thus, denoting
that the improvements found in our study would be of
significance to the participants. The improvement in qual-
ity of life is fairly similar to that found in Ferrazzoli and
colleagues’ study where an 8.3 point improvement was
reported following a 10-week multidisciplinary rehabilita-
tion intervention.18 Additionally, their improvement sus-
tained, although not as markedly, at the four-month
follow-up. In comparison, our study was one of a rela-
tively short duration, which could explain the short-term
improvements, and did not include a follow-up assessment
beyond the three-week follow-up.
After completing the baseline functional status testing, one
would assume that the adversities that were found, among
others, became targeted in the exercise program the partici-
pants underwent and worked on during their three-weekmulti-
disciplinary rehabilitation program. Consequently, one
explanation for the increase in the reported functional status
could be that the participants worked on improving the physi-
cal adversities during the rehabilitation program. Improved
functioning has similarly been found in other studies.17,36
Additionally, the multidisciplinary rehabilitation program
may have provided tools for participants to better self-manage
their disease, resulting in higher general self-efficacy at fol-
low-up. Thus, higher levels of quality of life at the end of the
rehabilitation program could be an effect of improved func-
tioning and general self-efficacy.1,2,10,18 Another explanation
for the positive results could be that the participants experi-
enced that there is hope, even for a progressive disease such as
Parkinson’s disease, although there is no cure.37,38
When including Parkinson’s disease duration, func-
tional status, baseline general self-efficacy, and baseline
quality of life in Model 2 of the regression analyses, we
found better initial functional status and lower initial levels
in quality of life to be associated with more improvements
in quality of life. One interpretation of the findings is that
participants who had better initial functional status were
able to utilize and benefitted more from the rehabilitation
program compared with those with poorer who reported
lower initial functional status. Moreover, participants with
poorer initial levels of functional status may be in need of
a rehabilitation program of longer duration to benefit from
it. Reduced functional status has been linked with reduced
independence, inability to perform ADLs, and decreased
mobility.39,40 As symptoms are worse, participants’ scores
in functional status would reflect this notion. Thus, sub-
stantial improvements in quality of life among those with
poorer functioning appear less likely.
A broadly composed measure of quality of life, like the
PDQ-39, is likely to be quite stable over time, reflecting that
quality of life is in fact a more generic concept than, for
example, emotions tied to immediate circumstances. In addi-
tion, the shorter the time span between themeasurements, the
stronger the association between quality of life scores. One
could, therefore, expect patients who initially report higher
baseline quality of life to report higher follow-up quality of
life. Results supporting this idea have been found in a study
of stroke patients who participated in a rehabilitation pro-
gram (mean duration of 57 days), where baseline quality of
life was found to predict follow-up quality of life.41
Given the brevity of the rehabilitation program pro-
vided in our study, we found it more appropriate to associ-
ate initial measures with changes in quality of life instead
of the follow-up measure. We found that higher initial
quality of life scores (ie, lower quality of life) was strongly
associated with more improvement in quality of life at
three weeks follow-up. Clearly, participants with lower
initial levels of quality of life indicated that the partici-
pants had troubled feelings about their performance capa-
city and other aspects of their life circumstances.
However, considering the two findings in combination
may be worthwhile. During the rehabilitation program,
those with better functional capacity would likely be
those who could more readily change their performance
of daily life activities, and subsequently their beliefs and
feelings related to their life circumstances in a more gen-
eral sense. Those with poorer initial functioning may not
have experienced similar changes in what they can do in
their daily life, and therefore, their quality of life have may
not have been as susceptible to change. Thus, the com-
bined results indicate that those with better initial function-
ing, but who were inclined toward considering their own
functioning and general life circumstances as poor, had the
best prospects of improving quality of life over the course
of a brief program.
To illustrate the main findings from the regression
analysis (see Table 2), we examined how the changes in
quality of life were moderated by the participants’ initial
functional status and quality of life. The results showed
that baseline levels of these measures moderated the
changes in quality of life, most apparent in the sharp
improvement for those whose initial quality of life was
in the poorer half of the scores (see Figures 1 and 2).
However, the participants with the sharpest improvement
still reported poorer quality of life compared with the
participants who reported better initial quality of life.
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Study limitations
This study is limited by a relatively small sample size. The
sample was also one of convenience, thus, generalizations
should be made with caution. Participants may have inter-
preted the questionnaires differently as well as becoming
disinterested while filling them out, possibly resulting in
skewed results. We used a general measure for measuring
quality of life. However, one could assume that certain
aspects of quality of life change more, while others change
less, but this is not assessed in the present study.
The participants’ level of activity throughout the stay
was not recorded. Participation may have varied substan-
tially from person to person, which could have affected the
results. Which activities the individual patient participated
in during the multidisciplinary rehabilitation program was
not accounted for, and future studies should report more
clearly both the level and the content of activity participa-
tion during the rehabilitation program. Medication, and/or
adjustment of medication during the stay, was not accounted
for, and this could have influenced the results. Additionally,
we report findings from a brief rehabilitation program, and
sustained changes are not reported. With this in mind, one
should, therefore, use these results with caution.
Conclusion
This study showed that persons with Parkinson’ disease
reported positive changes in functional status, general self-
efficacy, and quality of life following a brief multidisci-
plinary rehabilitation program. Participants with higher
functional status and lower levels of quality of life at the
beginning of the rehabilitation program, reported more
improvement in quality of life at three weeks follow-up,
compared to their counterparts. Moreover, the study sug-
gests that actual functioning in persons with Parkinson’s
disease is a better predictor of improved quality of life
than self-efficacy beliefs and that those who have lower
levels of initial quality of life benefit more from
rehabilitation.
Data Availability
The dataset used to support the findings of this study will
be available from the authors on reasonable request when
the research project is completed.
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